Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis.

Autor:	Ellsworth RE; Clinical Breast Care Project, Murtha Cancer Center, Windber, PA, USA., Toro AL; Clinical Breast Care Project, Windber Research Institute, Windber, PA, USA., Blackburn HL; Clinical Breast Care Project, Windber Research Institute, Windber, PA, USA., Decewicz A; Clinical Breast Care Project, Windber Research Institute, Windber, PA, USA., Deyarmin B; Clinical Breast Care Project, Windber Research Institute, Windber, PA, USA., Mamula KA; Clinical Breast Care Project, Windber Research Institute, Windber, PA, USA., Costantino NS; Clinical Breast Care Project, Windber Research Institute, Windber, PA, USA., Hooke JA; Clinical Breast Care Project, Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD, USA., Shriver CD; Clinical Breast Care Project, Murtha Cancer Center, Walter Reed National Military Medical Center, Bethesda, MD, USA., Ellsworth DL; Clinical Breast Care Project, Windber Research Institute, Windber, PA, USA.
Jazyk:	angličtina
Zdroj:	Cancer growth and metastasis [Cancer Growth Metastasis] 2015 Jul 20; Vol. 8, pp. 15-24. Date of Electronic Publication: 2015 Jul 20 (Print Publication: 2015).
DOI:	10.4137/CGM.S29490
Abstrakt:	Molecular heterogeneity within primary breast carcinomas and among axillary lymph node (LN) metastases may impact diagnosis and confound treatment. In this study, we used short tandem repeated sequences to assess genomic heterogeneity and to determine hereditary relationships among primary tumor areas and regional metastases from 30 breast cancer patients. We found that primary carcinomas were genetically heterogeneous and sampling multiple areas was necessary to adequately assess genomic variability. LN metastases appeared to originate at different time periods during disease progression from different sites of the primary tumor and the extent of genomic divergence among regional metastases was associated with a less favorable patient outcome (P = 0.009). In conclusion, metastasis is a complex process influenced by primary tumor heterogeneity and variability in the timing of dissemination. Genomic variation in primary breast tumors and regional metastases may negatively impact clinical diagnostics and contribute to therapeutic resistance.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu